Insider Trading Alert - Splunk And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 10, 2013, 38 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $577.20 to $11,029,512.00.

Highlighted Stocks Traded by Insiders:

Splunk (SPLK) - FREE Research Report

Neustaetter Thomas M who is Director at Splunk sold 1,500 shares at $56.08 on Oct. 10, 2013. Following this transaction, the Director owned 94,103 shares meaning that the stake was reduced by 1.57% with the 1,500 share transaction.

The shares most recently traded at $60.04, up $3.96, or 6.59% since the insider transaction. Historical insider transactions for Splunk go as follows:

  • 4-Week # shares sold: 35,613
  • 12-Week # shares sold: 259,613
  • 24-Week # shares sold: 373,524

The average volume for Splunk has been 1.1 million shares per day over the past 30 days. Splunk has a market cap of $6.4 billion and is part of the technology sector and computer software & services industry. Shares are up 108.03% year to date as of the close of trading on Friday.

Splunk, Inc. provides software solutions that provide real-time operational intelligence. Currently there are 11 analysts that rate Splunk a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPLK - FREE

TheStreet Quant Ratings rates Splunk as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share. Get the full Splunk Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Salesforce.com (CRM) - FREE Research Report

Tomlinson Lawrence who is Director at Salesforce.com sold 2,000 shares at $50.36 on Oct. 10, 2013. Following this transaction, the Director owned 28,800 shares meaning that the stake was reduced by 6.49% with the 2,000 share transaction.

The shares most recently traded at $52.16, up $1.80, or 3.44% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 24,600
  • 12-Week # shares sold: 39,076
  • 24-Week # shares sold: 47,476

The average volume for Salesforce.com has been 5.1 million shares per day over the past 30 days. Salesforce.com has a market cap of $31.1 billion and is part of the technology sector and computer software & services industry. Shares are up 24.07% year to date as of the close of trading on Friday.

salesforce.com, inc. provides enterprise cloud computing solutions to various businesses and industries worldwide. Currently there are 23 analysts that rate Salesforce.com a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings rates Salesforce.com as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full Salesforce.com Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Williams-Sonoma (WSM) - FREE Research Report

Lynch Mike who is Director at Williams-Sonoma sold 5,445 shares at $52.91 on Oct. 10, 2013. Following this transaction, the Director owned 11,964 shares meaning that the stake was reduced by 31.28% with the 5,445 share transaction.

The shares most recently traded at $54.17, up $1.26, or 2.33% since the insider transaction. Historical insider transactions for Williams-Sonoma go as follows:

  • 12-Week # shares sold: 16,359
  • 24-Week # shares sold: 16,359

The average volume for Williams-Sonoma has been 965,600 shares per day over the past 30 days. Williams-Sonoma has a market cap of $5.4 billion and is part of the services sector and retail industry. Shares are up 28.01% year to date as of the close of trading on Friday.

Williams-Sonoma, Inc. operates as a multi-channel specialty retailer of home products. It operates in two segments, Direct-to-Customer and Retail. The stock currently has a dividend yield of 2.21%. The company has a P/E ratio of 53.4. Currently there are 5 analysts that rate Williams-Sonoma a buy, no analysts rate it a sell, and 17 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WSM - FREE

TheStreet Quant Ratings rates Williams-Sonoma as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, good cash flow from operations and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Williams-Sonoma Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 21,900 shares at $9.36 on Oct. 10, 2013. Following this transaction, the CEO & Chairman owned 136.8 million shares meaning that the stake was reduced by 0.02% with the 21,900 share transaction.

The shares most recently traded at $9.95, up $0.59, or 5.95% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 24-Week # shares bought: 4,300

The average volume for Opko Health has been 2.7 million shares per day over the past 30 days. Opko Health has a market cap of $3.5 billion and is part of the health care sector and health services industry. Shares are up 81.5% year to date as of the close of trading on Friday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

RF Micro Devices (RFMD) - FREE Research Report

Priddy William A who is VP Administration and CFO at RF Micro Devices sold 28,385 shares at $5.99 on Oct. 10, 2013. Following this transaction, the VP Administration and CFO owned 800,964 shares meaning that the stake was reduced by 3.42% with the 28,385 share transaction.

The shares most recently traded at $5.88, down $0.11, or 1.87% since the insider transaction. Historical insider transactions for RF Micro Devices go as follows:

  • 4-Week # shares sold: 60,100
  • 12-Week # shares sold: 386,827
  • 24-Week # shares sold: 774,103

The average volume for RF Micro Devices has been 4.4 million shares per day over the past 30 days. RF Micro Devices has a market cap of $1.6 billion and is part of the technology sector and electronics industry. Shares are up 28.79% year to date as of the close of trading on Friday.

RF Micro Devices, Inc. engages in the design, development, manufacture, and marketing of radio frequency (RF) solutions for original equipment manufacturers and original design manufacturers in wireless and wired communications applications in the United States and internationally. Currently there are 12 analysts that rate RF Micro Devices a buy, 2 analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on RFMD - FREE

TheStreet Quant Ratings rates RF Micro Devices as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow. Get the full RF Micro Devices Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec